Why Is Gene Therapy Developer Benitec Biopharma Stock Trading Higher On Thursday?
Latest clinical data on BB-301 treatment for OPMD. Positive results in swallowing improvement. Benitec Biopharma announces interim findings and $40 million PIPE financing.